Live from the NIH registry
Studies recruiting near Tampa right now
Top 25 of 1,310 recruiting studies, sorted by proximity — each links to its official registry page
Using Aspirin to Improve Immunological Features of Ovarian Tumors
Ovarian Cancer, Fallopian Tube Cancer
EARLY/Phase 1
Interventional 100 participants sought
Moffitt Cancer Center — Tampa, Florida (3.4 mi)
· Sponsor: H. Lee Moffitt Cancer Center and Research Institute
A Study of Zasocitinib in Adults With Hidradenitis Suppurativa
Hidradenitis Suppurativa
Phase 2
Interventional 90 participants sought
Advanced Clinical Research Institute — Tampa, Florida (3.4 mi)
· Sponsor: Takeda
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)
Neovascular Age-related Macular Degeneration
Phase 4
Interventional 188 participants sought
Retina Vitreous Associates of Florida — St. Petersburg, Florida (21.1 mi)
· Sponsor: Genentech, Inc.
alloSHRINK - Standard cHemotherapy Regimen and Immunotherapy With Allogeneic NKG2D-based CYAD-101 Chimeric Antigen Receptor T-cells
Unresectable Metastatic Colorectal Cancer
Phase 1
Interventional 49 participants sought
Moffit Cancer Center — Tampa, Florida (3.4 mi)
· Sponsor: Celyad Oncology SA
Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design
Fibromyalgia
Phase 3
Interventional 620 participants sought
Clinical Research Site — Tampa, Florida (3.4 mi)
· Sponsor: Axsome Therapeutics, Inc.
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
Solid Tumor Cancer, Locally Advanced
Phase 1, Phase 2
Interventional 480 participants sought
Avenzo Therapeutics Recruiting Site — Tampa, Florida (3.4 mi)
· Sponsor: Avenzo Therapeutics, Inc.
Abatacept for the Treatment of Common Variable Immunodeficiency With Interstitial Lung Disease
Interstitial Lung Disease, Common Variable Immunodeficiency
Phase 2
Interventional 38 participants sought
University of South Florida — Tampa, Florida (3.4 mi)
· Sponsor: Children's Hospital Medical Center, Cincinnati
Zenith® Fenestrated+ Clinical Study
Aortic Aneurysm, Abdominal, Juxtarenal Aortic Aneurysm
N/A
Interventional 105 participants sought
Tampa General Hospital — Tampa, Florida (3.4 mi)
· Sponsor: Cook Research Incorporated
Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).
Systemic Lupus Erythematosus
Phase 3
Interventional 550 participants sought
Clinical Research of West Florida Inc — Tampa, Florida (3.4 mi)
· Sponsor: Novartis Pharmaceuticals
A Study of Dotinurad Versus Allopurinol in Participants With Gout
Gout
Phase 3
Interventional 500 participants sought
Clinical Research Trials of Florida — Tampa, Florida (3.4 mi)
· Sponsor: Crystalys Therapeutics
A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension
Uncontrolled Hypertension
Phase 2
Interventional 280 participants sought
Retension Clinical Site — Tampa, Florida (3.4 mi)
· Sponsor: Retension Pharmaceuticals. Inc.
Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer 2
Bladder Cancer, Recurrent Bladder Cancer
N/A
Observational 408 participants sought
H. Lee Moffitt Cancer Center & Research Institute — Tampa, Florida (3.4 mi)
· Sponsor: University of Washington
A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy
Geographic Atrophy, Macular Degeneration
N/A
Observational 500 participants sought
Eye Physicians of Pinellas PA dba Eye Institute of West Florida — Tampa, Florida (3.4 mi)
· Sponsor: Astellas Pharma Global Development, Inc.
Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD
Atherosclerotic Cardiovascular Disease (ASCVD)
Phase 3
Interventional 340 participants sought
University Of South Florida — Tampa, Florida (3.4 mi)
· Sponsor: Novartis Pharmaceuticals
A Study to Evaluate the Efficacy and Safety of E2086 in Adults With Narcolepsy
Narcolepsy
Phase 2
Interventional 64 participants sought
Meris Clinical Research-310 Oakfield Dr — Brandon, Florida (10.5 mi)
· Sponsor: Eisai Inc.
Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
Recurrent Head and Neck Squamous Cell Carcinoma, Recurrent Hypopharyngeal Squamous Cell Carcinoma
Phase 2
Interventional 188 participants sought
Moffitt Cancer Center-International Plaza — Tampa, Florida (3.4 mi)
· Sponsor: National Cancer Institute (NCI)
Intervention to Prevent Behavioral Health Symptoms Among Pandemic Affected Children
Emotional Distress, Prosocial Behavior
N/A
Interventional 800 participants sought
R'Club Child Care, Inc. — St. Petersburg, Florida (21.1 mi)
· Sponsor: University of Illinois at Urbana-Champaign
Real-World Data Collection of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis When Used in Covered Endovascular Reconstruction of the Aortic Bifurcation (CERAB) to Treat Aortoiliac Occlusive Disease
Aortoiliac Occlusive Disease
N/A
Observational 158 participants sought
University of South Florida — Tampa, Florida (3.4 mi)
· Sponsor: W.L.Gore & Associates
Safety and Effectiveness of the Optilume® BPH Catheter System in a Post-Market Study
Benign Prostatic Hyperplasia
N/A
Interventional 92 participants sought
Florida Urology Partners, LLP — Tampa, Florida (3.4 mi)
· Sponsor: Urotronic Inc.
A Study to Assess NAV-240 in Adult Participants With Hidradenitis Suppurativa
Hidradenitis Suppurativa (HS)
Phase 2
Interventional 150 participants sought
ForCare Clinical Research — Tampa, Florida (3.4 mi)
· Sponsor: Navigator Medicines, Inc.
Phase 1/2 Study of PYX-201 in Combination With Pembrolizumab in Advanced Solid Tumors
Advanced Solid Tumors
Phase 1, Phase 2
Interventional 220 participants sought
Moffitt Cancer Center — Tampa, Florida (3.4 mi)
· Sponsor: Pyxis Oncology, Inc
Multicenter HomeVENT: Home Values and Experiences Navigation Track
Pediatric ALL, Respiratory Insufficiency
N/A
Interventional 600 participants sought
Johns Hopkins All Childrens Hospital — Tampa, Florida (3.4 mi)
· Sponsor: Johns Hopkins University
A Study to Assess Real-World Use and Outcomes of TAR-200 for Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) in the United States
Non-Muscle Invasive Bladder Neoplasms
N/A
Observational 150 participants sought
Florida Urology Partners — Wimauma, Florida (21.4 mi)
· Sponsor: Janssen Research & Development, LLC
A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)
Relapsed Refractory Multiple Myeloma
Phase 3
Interventional 508 participants sought
Research Site — Tampa, Florida (3.4 mi)
· Sponsor: AstraZeneca
Evaluating a Nonessential Amino Acid Restriction (NEAAR) Medical Food With Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer (LARC)
Rectal Cancer
N/A
Interventional 30 participants sought
University of South Florida — Tampa, Florida (3.4 mi)
· Sponsor: University of South Florida